3138 related articles for article (PubMed ID: 23877944)
1. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.
Schuetz P; Briel M; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Mueller B
Clin Infect Dis; 2012 Sep; 55(5):651-62. PubMed ID: 22573847
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.
Smedemark SA; Aabenhus R; Llor C; Fournaise A; Olsen O; Jørgensen KJ
Cochrane Database Syst Rev; 2022 Oct; 10(10):CD010130. PubMed ID: 36250577
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
Schuetz P; Chiappa V; Briel M; Greenwald JL
Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of procalcitonin in respiratory tract infections across clinical settings.
Kutz A; Briel M; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Luyt CE; Chastre J; Tubach F; Mueller B; Schuetz P
Crit Care; 2015 Mar; 19(1):74. PubMed ID: 25887979
[TBL] [Abstract][Full Text] [Related]
11. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis.
Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Annane D; Reinhart K; Falsey AR; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Oliveira CF; Maravić-Stojković V; Verduri A; Beghé B; Cao B; Shehabi Y; Jensen JS; Corti C; van Oers JAH; Beishuizen A; Girbes ARJ; de Jong E; Briel M; Mueller B
Lancet Infect Dis; 2018 Jan; 18(1):95-107. PubMed ID: 29037960
[TBL] [Abstract][Full Text] [Related]
12. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.
Tonkin-Crine SK; Tan PS; van Hecke O; Wang K; Roberts NW; McCullough A; Hansen MP; Butler CC; Del Mar CB
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012252. PubMed ID: 28881002
[TBL] [Abstract][Full Text] [Related]
13. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
[TBL] [Abstract][Full Text] [Related]
14. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
[TBL] [Abstract][Full Text] [Related]
16. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
Schuetz P; Balk R; Briel M; Kutz A; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Luyt CE; Chastre J; Tubach F; Mueller B; Lacey MJ; Ohsfeldt RL; Scheibling CM; Schneider JE
Clin Chem Lab Med; 2015 Mar; 53(4):583-92. PubMed ID: 25581762
[TBL] [Abstract][Full Text] [Related]
18. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
20. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
